U.S. markets closed
  • S&P 500

    3,298.46
    +51.87 (+1.60%)
     
  • Dow 30

    27,173.96
    +358.56 (+1.34%)
     
  • Nasdaq

    10,913.56
    +241.26 (+2.26%)
     
  • Russell 2000

    1,474.91
    +23.09 (+1.59%)
     
  • Crude Oil

    40.04
    -0.27 (-0.67%)
     
  • Gold

    1,864.30
    -12.60 (-0.67%)
     
  • Silver

    22.99
    -0.21 (-0.91%)
     
  • EUR/USD

    1.1639
    -0.0037 (-0.31%)
     
  • 10-Yr Bond

    0.6590
    -0.0070 (-1.05%)
     
  • GBP/USD

    1.2744
    -0.0007 (-0.06%)
     
  • USD/JPY

    105.5590
    +0.1570 (+0.15%)
     
  • BTC-USD

    10,711.94
    +14.95 (+0.14%)
     
  • CMC Crypto 200

    230.19
    +12.36 (+5.67%)
     
  • FTSE 100

    5,842.67
    +19.89 (+0.34%)
     
  • Nikkei 225

    23,204.62
    +116.82 (+0.51%)
     

Company News for May 26, 2020

Zacks Equity Research
  • Shares of Navidea Biopharmaceuticals, Inc. NAVB surged 91.3% after the biopharmaceutical company announced positive preliminary results from the second interim analysis of its ongoing NAV3-31 Phase 2B study.

  • Shares of Xeris Pharmaceuticals, Inc. XERS soared 28% after the specialty pharmaceutical company reported findings from outpatient portion of Phase 2 proof-of-concept study of its developmental ready-to-use glucagon in patients at risk of postprandial hypoglycemia following bariatric surgery.

  • Shares of T2 Biosystems, Inc. TTOO rose 12.8% after the in vitro diagnostics companysaid it expects to ship first SARS-CoV-2 tests to American customers as early as June-end.

  • Shares of Splunk Inc. SPLK gained 12.7% after the company reported first-quarter fiscal 2021 non-GAAP loss of 56 cents per share, which was lesser than the Zacks Consensus Estimate of a loss of 57 cents.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Splunk Inc. (SPLK) : Free Stock Analysis Report
 
Navidea Biopharmaceuticals, Inc. (NAVB) : Free Stock Analysis Report
 
T2 Biosystems, Inc. (TTOO) : Free Stock Analysis Report
 
Xeris Pharmaceuticals, Inc. (XERS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research